Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation TCT 2022

TCT 377: Automated Robotic TCD for RLS detection in the evaluation of patients with Cryptogenic Stroke

Presenter: Ruchir Shah

September 19, 2022

Presentation TCT 2022

TCT 333: Effect of stroke on readmissions and cardiovascularoutcomes in patients with Mitraclip.

Presenter: Nirav Patel

September 19, 2022

Presentation TCT 2022

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Tanesh Ayyalu

September 18, 2022

Presentation TCT 2022

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

Presenter: Arpanjeet Kaur

September 18, 2022

Presentation TCT 2022

Systematic Use: Unravelling the Stroke Story

Presenter: Nicolas M. Van Mieghem

September 17, 2022

Presentation TCT 2022

Robotics and Tele-Intervention: Why Stroke May Be the Place Where Intravascular Robotics Really Take Off

Presenter: Raymond Turner

September 16, 2022

Presentation TCT 2022

Innovations in Systems of Care for Acute Stroke Treatment: The Need for Speed

Presenter: Ajit Puri

September 16, 2022

Presentation TCT 2022

Breaking Down Barriers to Access: Lessons Learned From a Successful Stroke Interventional Program

Presenter: Phil Taussky

September 16, 2022

Presentation TCT 2022

Historical Background: Multiple Waves of Innovation Transformed Acute Stroke Intervention

Presenter: Adnan Siddiqui

September 16, 2022

Presentation ESC 2022

A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial

Presenter: Valentin Fuster

August 29, 2022

Presentation TVT 2022

Pharmacologic "Protection" to Reduce Strokes After TAVR: Current Evidence and Recommendations

Presenter: George Dangas

June 10, 2022

Presentation TVT 2022

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

Presenter: Amar Krishnaswamy

June 10, 2022

Presentation TVT 2022

Clinical Trial Pathways and Study Designs: Embolic Capture vs Deflection Devices

Presenter: Alexandra Lansky

June 10, 2022

Presentation TVT 2022

Novel Embolic Protection Technologies: The Current State of Play

Presenter: Giora Weisz

June 10, 2022

Presentation TVT 2022

Stroke Prevention With Sentinel: Update From PROTECTED TAVR and BHF PROTECT-TAVI

Presenter: Samir Kapadia

June 10, 2022

Presentation TVT 2022

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting with Recurrent Stroke

Presenter: Nahyr Lugo-Fagundo

June 09, 2022

Presentation TVT 2022

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

Presenter: Toshiaki Isogai

June 09, 2022

Presentation TVT 2022

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting With Recurrent Stroke

Presenter: Nahyr Lugo-Fagundo

June 09, 2022

Presentation Miami Valves 2022

Do We Understand Neuroprotection Better?

Presenter: Carlos Alfonso

February 03, 2022

Advertisement

TCT 377: Automated Robotic TCD for RLS detection in the evaluation of patients with Cryptogenic Stroke

TCT 333: Effect of stroke on readmissions and cardiovascularoutcomes in patients with Mitraclip.

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

Systematic Use: Unravelling the Stroke Story

Robotics and Tele-Intervention: Why Stroke May Be the Place Where Intravascular Robotics Really Take Off

Innovations in Systems of Care for Acute Stroke Treatment: The Need for Speed

Breaking Down Barriers to Access: Lessons Learned From a Successful Stroke Interventional Program

Historical Background: Multiple Waves of Innovation Transformed Acute Stroke Intervention

A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial

Pharmacologic "Protection" to Reduce Strokes After TAVR: Current Evidence and Recommendations

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

Clinical Trial Pathways and Study Designs: Embolic Capture vs Deflection Devices

Novel Embolic Protection Technologies: The Current State of Play

Stroke Prevention With Sentinel: Update From PROTECTED TAVR and BHF PROTECT-TAVI

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting with Recurrent Stroke

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting With Recurrent Stroke

Do We Understand Neuroprotection Better?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content